-transparent.png){kind=logo}
The glycoprotein (GP)Ib-IX receptor complex plays a critical role in platelet physiology and pathology. Its interaction with von Willebrand factor (VWF) on the subendothelial matrix instigates platelet arrest at the site of vascular injury and is vital to primary hemostasis. Its reception to other ligands and counter-receptors in the bloodstream also contribute to various processes of platelet biology that are still being discovered. While its basic composition and its link to congenital bleeding disorders were well documented and firmly established more than 25 years ago, recent years have witnessed critical advances in the organization, dynamics, activation, regulation, and functions of the GPIb-IX complex. This review summarizes important findings and identifies questions that remain about this unique platelet mechanoreceptor complex.
M Edward Quach, and
Renhao Li
January 1991,
Progress in hemostasis and thrombosis,
M Edward Quach, and
Renhao Li
February 1994,
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
M Edward Quach, and
Renhao Li
September 1997,
Current opinion in hematology,
M Edward Quach, and
Renhao Li
February 2001,
Proceedings of the National Academy of Sciences of the United States of America,
M Edward Quach, and
Renhao Li
August 2022,
Platelets,
M Edward Quach, and
Renhao Li
June 2003,
Current medicinal chemistry. Cardiovascular and hematological agents,
M Edward Quach, and
Renhao Li
December 2004,
Cellular signalling,
M Edward Quach, and
Renhao Li
May 2014,
Arteriosclerosis, thrombosis, and vascular biology,
M Edward Quach, and
Renhao Li
March 1998,
Thrombosis and haemostasis,
M Edward Quach, and
Renhao Li
April 2014,
Transfusion medicine reviews,
